海外子会社における進化の失敗

DOI Web Site

書誌事項

タイトル別名
  • THE FAILURE OF MULTINATIONAL SUBSIDIARY EVOLUTION : A CASE OF THE FOREIGN PHARMACEUTICAL ENTERPRISE IN JAPAN
  • 海外子会社における進化の失敗 : 外資系製薬企業を事例として
  • カイガイ コガイシャ ニ オケル シンカ ノ シッパイ : ガイシケイ セイヤク キギョウ オ ジレイ ト シテ
  • ──外資系製薬企業を事例として──

この論文をさがす

抄録

<p>　Previous research has explored the factors which facilitate subsidiary evolution and the processes associated with these evolutions. However, the processes and the reasons for failure of subsidiary evolution have not been adequately examined. There are foreign subsidiaries which have succeeded in evolving once, but failed in subsequent evolutions. The reasons for their inability to realize sustainable evolution have not been examined.</p><p>　Consequently, this paper examines the process of failure in subsidiary evolution and discusses the reasons why foreign subsidiaries fail in their evolutions. It considers, in particular, "subsidiary initiative" which appears to facilitate subsidiary evolution.</p><p>　The paper focuses on the processes associated with Nihon Schering, once a Japanese subsidiary of the German pharmaceutical company, Schering AG. In this case, the subsidiary had evolved, but was not successful in carrying out their next subsidiary evolution. Moreover, Nihon Schering had undertaken subsidiary initiative, but could not make a sustainable evolution. Why did it fail at subsidiary evolution in spite of undertaking subsidiary initiative?</p><p>　The results from the analysis of this case conclude that subsidiary initiative does not always facilitate subsidiary evolution. Preceding subsidiary evolution sometimes results in the misunder-standing of the actual capabilities of the subsidiary. In this situation, the subsidia1y evolution fails even with subsidiary initiative.</p>

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ